Two major immunoreactive proteins of Mr 41,7Q0 and 36,100 have been detected in crude mycelial extracts with polyclonal antibodies raised against arginase purified from Neurospora crassa. The latter corresponded to the protein used to obtain the antibodies. Both polypeptides were either missing or present in very low amounts in mutant strains having little or no detectable arginase activity. The relative proportion of the two species was altered in strains containing the nitrogen catabolite regulatory mutation nit-2. Peptide mapping indicated that the two species are very closely related, but several of the peptides which appeared to be identical by staining reacted differently with the antibodies. Both species were produced by in vitro translation of poly(A)t mRNA, although the larger species was produced to a much smaller extent, than was expected from its abundance in vivo. The results suggest the existence of multiple forms of arginase in N. crassa which differ in their response to nitrogen catabolite regulation.
bolic enzyme which is maximally active under conditions of nitrogen starvation (24) or arginine excess (40) . The specific activity of arginase increases threefold when mycelia are grown with arginine as the sole nitrogen source. This induction is accompanied by a 75-fold increase in the cytoplasmic pool of arginine (13) . However, it is not known whether this increase jn enzyme activity results from de novo protein synthesis or from activation of preexisting arginase molecules.
When a wild-type strain is grown in medium containing glutamine, glutamate, oF ammonium, the addition of arginine causes only a small increase in arginase specific activity (37) . This effect has been termed "nitrogen catabolite control." Arginase is present at fully induced levels in mutant strains having the am mutation (lacking NADP:glutamate dehydrogenase, and hence having low glutamate and glutamine pools) whether the strain is grown in arginine alone or in arginine-ammonium medium (37) . This suggests that nitrogen catabolite control is mediated by glutamine or glutamate or by a secondary effect directly influenced by these two species.
One known nitrogen catabolite repression mechanism is mediated by the nit-2 loc'us in N. crassa. The nit-2 gene product is a positive, trans-acting, pleiotropic regulatory effector necessary for expression of genes whose products are required for utilization of several alternative nitrogen sources (31) . Glutamine appears to cause inactivation of the nit-2 gene function, possibly through maintenance of an octameric glutamine synthetase, which may itself be the negative effector (14) . Arginase levels are unaffected by the nit-2 mutation (15) , indicating that the nit-2 regulatory mechanism is not responsible for nitrogen control of arginase levels. The nmr locus, which is responsible for nitrogen catabolite repression of nitrate assimilatory genes, also does not appear to regulate arginase levels in N. crassa (15, 36) .
We recently reported preliminary evidence for two and possibly three forms of arginase in N. crassa; two major immunoreactive proteins were detected by immunoblot analysis of crude extracts with antiserum directed against the purified enzyme (5a). The latter migrates as a single species during sodium dodecyl sulfate-gel electrophoresis. We have attempted to determine the structural relatedness of the two major immunoreactive proteins and to determine whether they arise from the same mRNA molecule. Also, because the mechanism of induction and its modulation by ritrogen source are unknown, the antiserum raised to the purified protein was used as a probe of protein levels in various nitrogen regulatory mutants.
Here we report that the two major protein species are structurally similar but appear to be encoded by separate poly(A)+ mRNA molecules. We found that the induction of arginase by arginine is due to de novo protein synthesis, resulting in an increased amount of both proteins. We failed to detect induction of arginase in log-phase mycelia of mutants containing the nit-2 mutation and observed a difference in the relative amounts of the two proteins.
MATERIALS AND METHODS
Strains and growth conditions. The N. crassa wild-type strain (LA1) and strains with four different aga mutations (alleles UM-903, UM-906, UM-908, and UM-913) were provided by R. H. Davis. The nitrogen regulatory mutant LA116 (nit-2, allele nr37) was obtained from the Fungal Genetics Stock Center, Kansas City, Mo. (FGSC983). The nitrogen regulatory mutant LA134 (nmr, allele 304) was provided by R. H. Garrett. All strains were grown at 30°C in Vogel minimal medium (38) with 1.5% sucrose as the carbon source. Where indicated, mycelia were grown in minimal medium with or without NH4NO3 and with 0.1% arginine. Strains having an aga mutation were supplementec with 0.02% putrescine when grown in arginine-supplemented medium. Mycelia were collected by filtration in the early-to mid-log phase unless noted otherwise. The mycelia to be used as a source of arginase for immunoblot analysis or peptide mapping could be stored at -200C until needed. Mycelia to be used for RNA purification were processed immediately.
For (12) . Urea was quantitated by the method of Archibald (3) . One unit of activity is the production of 1 ,umol of urea per min.
Protein assay. Protein was quantitated by the method of Bradford (6) with the Bio-Rad protein reagent concentrate microassay technique. Bovine serum albumin was used as a standard.
Antiserum generation. The antiarginase polyclonal serum used for these studies was described elsewhere (5a). Polyclonal antiserum raised against purified N. crassa ornithine carbamoyltransferase was the gift of Marjorie Bates.
Immunoglobulin purification. The immunoglobulin fraction from antiserum raised against arginase was purified by a modification of the technique of Levy and Sober (25) . Serum (5 ml) was brought to 33% saturation with solid (NH4)2SO4 and stirred for 30 min at 4°C. The solution was then centrifuged at 27,000 x g for 15 min at 2°C. The pellet was suspended in a small volume of 17.5 mM NaH2PO4 (pH 6.3) and dialyzed three times for 4 h against 1 liter of the same buffer at 4°C. The dialyzed solution was applied to a 5-by 2.5-cm DE-52 (Whatman) column equilibrated with the dialysis buffer at 4°C. Proteins were eluted with the dialysis buffer. Fractions having absorbance at 280 nm were pooled and concentrated (Amicon Ultrafiltration Cell, YM10 membrane) at 4°C. The purity of the immunoglobulin fraction was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with slab gels with a 10% resolving gel (Sa). Activity depletion assays (data not shown) indicated that 20 ,lI of immune serum or 10 RI of purified immune immunoglobulin was sufficient to precipitate all of the arginase activity and protein from 1 mg of crude extract protein (induced wild-type culture). Twice the volume of the corresponding preimmune serum or purified preimmune immunoglobulin contained an equivalent amount of immunoglobulin and was used as a control.
Immunoblot analysis. Mycelia were extracted with a Beadbeater (Biospec Products) apparatus or by sand grinding as described elsewhere (Sa). The extraction buffer contained 50 mM Tris chloride, 20 mM arginine, 1 mM EDTA, 1 mM 2-mercaptoethanol, and 1 mM phenylmethylsulfonyl fluoride (pH 7.5). The buffer used for preparation of extracts from strains having the aga mutation contained the above components plus 150 aureus cell suspension was added, and incubation was continued at 0°C for 60 min. The mixture was centrifuged in a microcentrifuge at 4°C for 2 min, and the supernatant was discarded. The pellet was washed by vigorous mixing in 500 ,u of 50 mM Tris chloride-150 mM NaCl-5 mM EDTA-1 mM 2-mercaptoethanol-1 mM phenylmethylsulfonyl fluoride-0.05% Triton X-100 (pH 7.5) and centrifuged for 1 min at room temperature, the supernatant was discarded. This washing step was repeated twice. Arginase-antibody complexes were solubilized by adding 40 RI of 3% sodium dodecyl sulfate and heating at 100°C for 5 min. The suspension was centrifuged at room temperature in a microcentrifuge, and the supernatant was retained for immunoblot analysis.
Immunoblot analysis of samples derived from 50 ,ug of crude extract protein was as described elsewhere (5a). Purified arginase (50 to 250 ng) was used as a standard for quantitation of the amount of arginase.
Peptide mapping. Cell extracts of strain LA116 grown in arginine-supplemented medium were prepared by sand grinding. The extraction buffer was 50 mM Tris chloride-20 mM arginine-150 mM NaCl-1 mM 2-mercaptoethanol-5 mM EDTA-1 mM phenylmethylsulfonyl fluoride (pH 7.5). The extract was centrifuged at 27,000 x g for 15 min at 2°C to remove cell debris. The supematant was centrifuged again in the microcentrifuge for 10 min at 4°C. Arginase was precipitated as described above, with the following exceptions: (i) a volume of extract containing 3 mg of protein was used; (ii) the sources of antibody were 10 pI of purified immune immunoglobulin or 40 ,u of decomplemented preimmune serum; (iii) the washing buffer contained 50 mM Tris chloride-150 mM NaCl-5 mM EDTA-1 mM 2-mercaptoethanol-1 mM phenylmethylsulfonyl fluoride (pH 7.5); (iv) the wash steps with the Tris chloride buffer were followed by two additional washes with water; and (v) the addition of 40 ,lA of 25 mM NaOH, followed by incubation at room temperature for 15 min, was used to solubilize the arginase-antibody complexes. Samples were prepared for electrophoresis as described elsewhere (5a).
The procedure of Josefsson and Randall (19) was used for peptide mapping. Immunoprecipitated samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis with a slab gel and a 10% resolving gel. The gel was stained with Coomassie brilliant blue (39) and then washed in water. Gel slices containing the individual proteins were incubated for 5 min in 1 ml of 1 x Laemmli stacking gel buffer (22) . Proteolysis and second-dimension electrophoresis were performed with a slab gel with a 5-cm-tall 2.5% stacking gel and a 15% resolving gel. Gel slices were diluted in lx Laemmli stacking gel buffer containing 0, 50, or 250 (or 200) ng of Staphylococcus aureus V8 protease. Molecular weight standards were 500 ng each of egg albumin (45,000), glyceraldehyde-3-phosphate dehydrogenase (36,000), ,Blactoglobulin (18,400), and ot-lactalbumin (14, 200) . Before samples were loaded on the gel, 10 ,u of a solution containing 0.05% bromphenol blue and 80% glycerol was added to all protease and molecular weight standard samples.
Silver staining. Gels to be silver stained were fixed in 25% isopropanol and 10% acetic acid overnight. The gels were washed in water, incubated in 50% methanol for at least 2 h, and then washed in water again. The positions of peptide bands were determined by silver staining by the Oakley et al. protocol (28) with the following modifications. A solution of 5% Norit-EX-purified (2), unbuffered glutaraldehyde was used as the source of glutaraldehyde. The final volume of the silver solution in ammonia was 200 ml instead of 100 ml, and staining was for 1 h instead of 15 min. The color development was terminated by incubation in 50% methanol for 5 min, followed by incubation in water.
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Immunoblot analysis. Gels were subjected to immunoblot analysis as outlined elsewhere (5a), except that the blotting step was overnight instead of for 2 h. Exposure was at 70°C with preflashed (23) film for 1 week.
Preparation of 35S-labeled arginase. Mycelia were extracted by sand grinding as described above with 50 mM Tris chloride-20 mM arginine-1 mM 2-mercaptoethanol-1 mM EDTA-1 mM phenylmethylsulfonyl fluoride (pH 7.5). The extract was centrifuged in the microcentrifuge for 5 min at 4°C, and the supernatant was retained. This was repeated once. The supernatant was assayed for protein amount and for incorporation of 35S into protein (alkali-stable, trichloroacetic acid-precipitable radioactivity).
A volume of the extract containing 7.2 x 106 cpm of 35S-labeled protein was treated with 10 ,u of purified immunoglobulin or 17 p.l of purified preimmune immunoglobulin at 0°C for 90 min. Then 20 ,ul of the 10% S. aureus cell suspension was added, and incubation was continued for an additional 30 min. The insoluble material was collected by centrifugation in a microcentrifuge for 2 min at 4°C, washed by suspension in 500 ,u1 of 50 mM Tris chloride-150 mM NaCl-0.1% sodium dodecyl sulfate-0.05% Triton X-100-5 mM EDTA-1 mM phenylmethylsulfonyl fluoride (pH 7.5), and collected by centrifugation in the microcentrifuge for 1 min at room temperature (1) . This was repeated three times. The insoluble material was then washed once more with 500 RI of 50 mM Tris chloride-1 mM 2-mercaptoethanol-0. 1 mM phenylmethylsulfonyl fluoride (pH 7.5). The antibodyantigen complexes were solubilized by treating with 35 pI of 3% sodium dodecyl sulfate at 100°C for 5 min. The suspension was centrifuged for 2 min at room temperature in the microcentrifuge, and the supernatant was withdrawn to a new tube. A volume of immune immunoglobulin-precipitated extract containing 4,000 cpm and a volume of preimmune immunoglobulin-precipitated extract containing an equivalent amount of immunoglobulin protein were subjected to electrophoresis.
Poly(A)+ mRNA purification. The procedure used to purify poly(A)+ mRNA was previously described (27) . The average yield of poly(A)+ mRNA from 16 g (wet weight) of N. crassa mycelia was 120 ,ug.
In vitro translation of poly(A)+ RNA. Poly(A)+ mRNA was translated in vitro with a nuclease-treated rabbit reticulocyte lysate system according to the instructions of the manufacturer (Promega Biotec). A volume of 12.5 p1 (12.5 jig) of poly(A)+ mRNA was treated with 1.3 ,u1 of 50 mM methylmercury hydroxide (5 mM, final concentration) at 0°C for 5 min to disrupt any secondary structure (9, 29 two nitrogen regulatory mutants grown on various nitrogen sources. Whole cell extracts of strains LA1 (wild type), LA116 (nit-2), and LA134 (nmr-J) grown on various nitrogen sources were prepared as described in Materials and Methods. Immunoblot analysis with antiserum directed against arginase was performed (Fig. 2) . Two major immunoreactive species (Mr 41,700 and 36,100) were detected in the extract from strain LA1 grown on ammonium-arginine (Fig. 2, lane  2) or arginine (lane 3) as the nitrogen source. The amounts of both major species and the arginase specific activity were greatest when arginine was the sole nitrogen source (Table 1) .
Strain LA116 (nit-2) had three major immunoreactive species (Fig. 2, lanes 4 through 6) . The higher-molecularweight species may be aggregates of the major immunoreactive species. The ratio of the 41,700-Mr protein to the 36,100-Mr protein differed from that of the wild type; this mutant also failed to achieve maximum induction of arginase activity ( Table 1 ). The differences in ratios and induction were exhibited only by log-phase mycelia; stationary-phase mycelia were identical to the wild type (data not shown). Strain LA134 (nmr-J) behaved similarly to the wild-type strain (Fig. 2, lanes 10 through 12) : levels of the two major immunoreactive species and the specific activity of arginase (data not shown) increased upon the addition of arginine to minimal medium and were greatest with arginine as the sole nitrogen source. Controls with preimmune sera were all blank (data not shown).
Densitometric tracings of purified arginase standards (Fig.  2, lanes 7 through 9) were used to generate a standard curve, which was used to determine the amount of the immunoreactive species in the extracts of LA1 and LA116 (Table 1 ). The specific activity of arginase correlated most closely with the amount of the 36,100-Mr species. The amount of the 41,700-Mr form was approximately the same for both strains grown in the same medium. This result was obtained in three separate experiments with log-phase mycelia. The appearance and abundance of the 26,800-Mr protein were more variable, suggesting that it may be a degradation product of one of the other proteins.
Peptide map analysis of the immunoreactive Mr 41,700 and 36,100 proteins. The in gel proteolysis technique of Cleveland et al. (10) used for peptide map analysis of the 41,700-and 36,100-Mr immunoreactive species. The S. aureus V8 protease, which cleaves on the carboxyl side of peptide bonds involving glutamate and aspartate (18) , was used for the proteolysis reactions.
The 41,700-and 36,100-Mr proteins without added protease (Fig. 3 , lanes 1 and 2) migrated as doublets when visualized by silver staining. The presence of doublets in the lanes corresponding to undigested protein is probably due to mechanical shearing or acid-catalyzed cleavage of the proteins during fixing and staining of the first-dimension gel. The addition of 50 ng of protease (Fig. 3, lanes 4 and 5) showed identical patterns of digestion products for the two proteins. The results of cleavage reactions with 250 ng of protease (Fig. 3, lanes 6 and 7) showed more complete digestion and patterns identical to those obtained with 50 ng of protease.
When analyzed by immunoblot analysis, reactions with 50 ng of S. aureus V8 protease with the 41,700-and 36,100-Mr proteins (Fig. 4, lanes 3 and 4, respectively) yielded several peptides which appeared to be common to both proteins and other peptides which differed in intensity or were unique to one of the two immunoreactive proteins. Treatment of the two proteins with 200 ng of protease (Fig. 4 , lanes 5 and 6) yielded several common peptides, but some of these differed in apparent amount between the proteins. The 36,100-Mr species (Fig. 4, lane 6 ) also had some unique peptides. Overall, the peptides generated ranged in size from Mr 8,700 to 27,100. The digestion products visualized in the immunoblot (Fig. 4) were of the same molecular weight as those seen in the silver-stained gels (Fig. 3) . However, the Immunoblot analysis of wild-type and mutant strains grown on various nitrogen sources. Lanes: 1 through 3, wild-type strain LA1 grown on NH4NO3, NH4NO3 plus arginine, and arginine alone, respectively, as the nitrogen source; 4 through 6, same except strain LA116 (nit-2); 7 through 9, 200, 100, and 50 ng, respectively, of purified arginase; 10 through 12, as lanes 1 through 3, except strain LA134 (nmr-1). relative intensity of specific peptide bands differed for the two proteins in Fig. 4 , whereas it was invariant in Fig. 3 .
Translation of poly(A)+ mRNA from the wild type and the nit-2 mutant. To further investigate the relationship between the two major immunoreactive species, poly(A)+ mRNA was purified from strains LA1 and LA116 and translated in vitro by using a rabbit reticulocyte lysate. An amount of purified antibody adequate to precipitate all reactive species was used for immunoprecipitation of translated proteins from samples containing equal amounts of incorporated 35S label after the in vitro translation reaction. Antibodies directed against ornithine carbamoyltransferase were used to standardize the amounts of translated material, since the level of this enzyme is not regulated by the nitrogen source in N. crassa (11) .
A crude extract of strain LA1 was uniformly labeled with 35SO4 and immunoprecipitated with immune immunoglobulins to provide a control for steady-state amounts of the two proteins (Fig. 5, lane 7) . Preimmune immunoglobulin yielded no proteins visible in crude extracts (data not shown) or in in vitro translation reactions (Fig. 5, lanes 2, 5, 9 , and 13). The 41,700-and 36,100-Mr species, plus some fainter bands, were produced by translation of RNA from strain LA1 (Fig. 5, lane 6) . The addition of 71 ng of unlabeled arginase to the completed translation mixture caused no apparent depletion of the two immunoreactive species (Fig.  5, lane 3) , but the addition of 710 ng of purified arginase reduced the amount of all species (Fig. 5, lane 4) .
RNA from strain LA116 yielded both species (Fig. 5, lane  8) , although the Mr 41,700 form could only be detected by densitometry. The 26,800-Mr protein visualized in immunoblot analyses of crude extracts of this strain was absent. Both protein bands were greatly reduced or absent when 710 ng of purified arginase was added (Fig. 5, lane 9) .
RNA from strains LA1 and LA116 yielded a dark band corresponding to a species of Mr 41,400 when treated with anti-ornithine carbamoyltransferase serum (Fig. 5, lanes 10  and 11) . Neither this band nor any of the background bands was affected by the addition of 710 ng of purified arginase (Fig. 5, lane 12) . Table 2 is a summary of the relative band intensities determined by densitometric tracing of the fluorograph in -~~~~d poly(A)' mRNA from strain LA1 and anti-arginase (AGA) antibody; 2, preimmune-precipitated protein and 710 ng of purified arginase; 5 and 6, preimmune immunoglobulin-and immune immunoglobulin-precipitated reactions, respectively; 3 and 4, immune immunoglobulin-precipitated material and 71 and 710 ng of purified arginase, respectively; 7, material precipitated with anti-arginase immunoglobulin from an 35S-labeled crude extract of strain LAL, 8 and 9, antiarginase-precipitated proteins from in vitro translation reactions with poly(A)+ mRNA from strain LA116, and 0 and 710 ng of purified arginase, respectively; 10 through 13, in vitro translation products immunoprecipitated with anti-omithine carbamoyltransferase antibody; 13, preimmune serum-precipitated material from a strain LA1 reaction; 10 and 11, immune serum-precipitated proteins from LA1 and LA116 reactions, respectively; 12, immune serumprecipitated material from a strain LA1 reaction and 710 ng of AGA. Abbreviations: I, immune antibody or serum used for precipitation; P, preimmune antibody or serum used for precipitation; M, molecular weight standards; OTC, ornithine carbamoyltransferase. Fig. 5 . The numbers have been corrected for differences in mRNA levels and translation efficiency by using the ornithine carbamoyltransferase as a control. The ratio of the two putative arginase species was considerably different than the steady-state level observed in crude extracts. Im- The amounts of the immunoreactive proteins in crude extracts varied as a function of the strain and the growth medium. Strain LA134 (nmr) and LA1 (wild type) exhibited the same increase in activity and immun,oreactive proteins in response to arginine in the growth medium. Thus, the nmr locus appears to have no effect on the induction of arginase. However, strain LA116 (nit-2) differed from strains LA1 and LA134 in several ways. The 26,800-Mr protein was present under all growth conditions tested, and this strain did not achieve the same levels of arginase activity as did strain LA1 when grown on arginine as the sole nitrogen source. The ratio of the 36;100-Mr protein to the 41,700-Mr protein was lower than that of strain LA1 under the same growth conditions due to a decrease in the amount of the 36,100-Mr form. The above observations are consistent with the 36,100-Mr species possessing all or most of the enzymatic activity of arginase. This is also supported by the results of purification of arginase from N. crassa: the 36,100-Ar protein was purified and possessed substantial activity (5a); chromatographic fractions containing predominantly the 41,700-Mr species had little or no enzymatic activity (Borkovich and Weiss, unpublished observations).
A defective arginine transport system in strain LA116 (15) may prevent entry of sufficient arginine into mycelia to achieve full induction of arginase. This effect would have to be seen in log-phase cultures grown on ammonium nitrate (results presented here) but not in stationary-phase mycelia cultured with ammonium tartrate and hypoxanthine' (14) , possibly due to the existence of a higher arginine pool in stationary-phase mycelia than in rapidly dividing log-phase cultures. However, because the Mr 41,700 species is present at the same levels in strain LA116 as in strain LA1, its regulation must be more sensitive to arginine than that of the 36,100-Mr species or influenced by a secondary metabolite or locus.
The 41,700-and 36,100-Mr proteins yielded identical silver-stained peptide maps after cleavage by S. aureus V8 protease, whereas immunoblot analysis yielded a slightly different pattern of digestion products for the two proteins. The differences seen by immunoblot analysis may be due to peptides of differing antigenicity but the same molecular weight. This suggests that the 41,700-and 36,100-Mr proteins may be distinct proteins with differing primary amino acid sequences. The overall difference in molecular weight is not apparent in the silver-stained maps: the peptides appear to be the same size. This may be due to (i) nonspecific protease digestion; (ii) differences in peptide sizes too small to be detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis; or (iii) differences at the amino or carboxyl terminus whose peptide product(s) from the 41,700-Mr protein run(s) at the dye front of the gel.
Translation of poly(A)' mRNA from strain LA1 grown with arginine as the nitrogen source resulted in the production of both the 41,700-and 36,100-Mr immunoreactive proteins. Poly(A)+ mRNA from strain LA116 also yielded both species. The appearance of both proteins as in vitro translation products suggests that the two proteins are not posttranslational variants of one another, whether by covalent modification or proteolysis. These observations suggest that the arginine-mediated control'of arginase levels occurs before final production of poly(A)+ mRNA, either at transcription, during splicing of the heterogeneous nuclear RNA, or in the stability of the RNA produced, and that induction of arginase is due to an increase in the level'of the 36,100-Mr protein.
The incorporation of 35SO4 into the two protein species was equal to the protein ratio found after immune replica analysis under the same conditions, indicating that sulfurcontaining amino acids are distributed proportionately between the two species. However, the ratio of the two proteins after in vitro translation was (26) .
A final possibility requires the existence of alternate promoters for transcription of separate heterogeneous nuclear RNA molecules encoding the 41,700-and 36,100-Mr proteins. The promoter for the 41,700-Mr species mRNA would have to be more sensitive to the arginine pool and result in greater increases in the amount of mRNA for the 41,700-Mr protein. However, the promoter for the 36,100-Mr protein mRNA would have to be transcribed more efficiently generally. Evidence for alternate promoters for a given gene has been reported for the yeast invertase gene (7) . Under various growth conditions, synthesis of the two mRNAs coding for the cytoplasmic and secreted forms of invertase can be coordinately or independently regulated (7, 30) . Another case of a single structural gene with multiple promoters is the glutamine synthetase gene in Escherichia coli (32) . This gene gives rise to two different mRNA rholecules, again with sotne coordinate and some independent means of regulation.
Determination of the exact relationship between the 41,700-and 36,100-Mr proteins obviously requires further investigation. However, it seems clear that the structure and regulation of arginase in N. crassa is fairly complex. The existence of multiple forms of arginase in different mammalian tissues and their differential regulation is well documented (4, 5, 16, 17, 20, 21, (33) (34) (35) . If the 41,700-and 36,100-Mr proteins both possessed arginase activity, then N. crassa would be the first nonvertebrate known to contain more than one form of arginase.
